All Posts: aging
34 Articles
- News Release
Some Cancer Therapies May Provide a New Way to Treat High Blood Pressure
Drugs designed to halt cancer growth may offer a new way to control high blood pressure (hypertension), say Georgetown University Medical Center investigators. The finding could…
November 18, 2017
- News Release
Agent Clears Toxic Proteins, Reduces Inflammation and Improves Cognition in Neurodegeneration Models
LONDON (July 16, 2017) — Researchers have found cell receptors abnormally overexpressed in post-mortem brains of those with Parkinson’s and Alzheimer’s diseases, and that…
June 27, 2017
- News Release
Steroid Originally Discovered in the Dogfish Shark Attacks Parkinson’s-Related Toxin in Animal Model
A naturally occurring steroid made by the dogfish shark prevents the buildup of a lethal protein in animal studies, reports an international team of researchers. The clustering…
December 19, 2016
- GUMC Stories
Nobel Prize-winning Science is Key to Georgetown Neurotherapeutic Research
Today, the 2016 Nobel Prize in the category of medicine or physiology was awarded to Yoshinori Ohsumi “for his discoveries of mechanisms for autophagy,” a…
October 3, 2016
- News Release
Georgetown Receives FDA Clearance to Conduct Clinical Trial with Nilotinib in Alzheimer’s Disease
Georgetown University Medical Center today announces the U.S. Food and Drug Administration has completed its review of an investigational new drug application (IND) for the use…
September 22, 2016
- News Release
Resveratrol Appears to Restore Blood-Brain Barrier Integrity in Alzheimer’s Disease
TORONTO (July 27, 2016) — Resveratrol, given to Alzheimer’s patients, appears to restore the integrity of the blood-brain barrier, reducing the ability of harmful immune…
July 23, 2016
- News Release
More Evidence in Quest to Repurpose Cancer Drugs for Alzheimer’s Disease
TORONTO – An FDA approved drug to treat renal cell carcinoma appears to reduce levels of a toxic brain protein linked to dementia in Alzheimer’s and Parkinson&;…
July 23, 2016
- News Release
Study: Cancer Drug Restores Brain Dopamine, Reduces Toxic Proteins in Parkinson, Dementia
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (July 11, 2016) — A small proof of concept study provides molecular evidence that an FDA-approved drug for leukemia…
July 5, 2016
- GUMC Stories
Georgetown Alzheimer’s Researcher Has “BrightFocus”
(June 12, 2016) — Xiong Jiang, PhD, believes there is a way to identify patients at an early enough stage in Alzheimer’s disease — well before clinical symptoms crop up;…
June 12, 2016
- News Release
Georgetown University and The Michael J. Fox Foundation for Parkinson’s Research Offer Fellowship in Regulatory Science
WASHINGTON and NEW YORK — Georgetown University Medical Center and The Michael J. Fox Foundation for Parkinson’s Research announce a fellowship in regulatory…
June 1, 2016